M&A Deal Summary |
|
|---|---|
| Date | 2012-12-11 |
| Target | Medicis Pharmaceutical |
| Sector | Life Science |
| Buyer(s) | Bausch Health |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.6B USD |
| Advisor(s) | Deutsche Bank Corporate & Investment Banking Roberts Mitani (Financial) Weil Gotshal & Manges Latham & Watkins (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 20,270 |
| Revenue | 9.6B USD (2024) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 21 of 36 |
| Sector: Life Science M&A | 15 of 22 |
| Type: Add-on Acquisition M&A Deals | 14 of 26 |
| State: Arizona M&A | 1 of 1 |
| Country: United States M&A | 10 of 23 |
| Year: 2012 M&A | 6 of 6 |
| Size (of disclosed) | 3 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-06-15 |
OraPharma
Horsham, Pennsylvania, United States OraPharma, Inc. is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression. |
Buy | $312M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-02-01 |
Natur Produkt
Saint Petersburg, Russia Natur Produkt provides (OTC) drugs segment in several categories marketed under the umbrella brand, Natur Produkt. Key brands include AntiGrippin, a leading cough and cold remedy, Anti Angin, Sage and Eucaplyptus MA. |
Buy | $163M |
